Clinical Trials Logo

Iron Deficiency Anemia clinical trials

View clinical trials related to Iron Deficiency Anemia.

Filter by:

NCT ID: NCT03944733 Not yet recruiting - Clinical trials for Iron Deficiency Anemia

Iron Status, Maternal Depressive Symptoms, and Mother-child Interactions

IDinteract
Start date: June 1, 2019
Phase: N/A
Study type: Interventional

This study aims to examine the relation between iron status and maternal-child interactions as well as maternal depressive symptoms in mothers from central Pennsylvania.

NCT ID: NCT03940430 Completed - Clinical trials for Iron Deficiency Anemia

Lactoferrin Versus Ferrous Sulfate in Management of Iron Deficiency Anemia Among Female Medical Ain Shams Students

Start date: September 10, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

This study aims to compare the efficacy of lactoferrin versus iron supplementation versus two combined supplementation on iron deficiency anemia in female medical Ain Shams students by using iron profile.

NCT ID: NCT03933813 Not yet recruiting - Anemia Clinical Trials

Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients

Start date: June 2019
Phase: Phase 1/Phase 2
Study type: Interventional

This study tests the hypothesis that IV iron sucrose infusions given to iron deficient ovarian cancer patients prior to debulking surgery can improve pre-operative iron stores and decrease transfusion of packed red blood cells in the peri-operative period. 21 participants at least 18 years of age with epithelial ovarian cancer of any stage requiring neoadjuvant chemotherapy and surgery will be enrolled. Participants will be on study for a period of up to 3 months.

NCT ID: NCT03915327 Not yet recruiting - Clinical trials for Iron Deficiency Anemia

Short-term Intravenous Iron Dextran for IDA

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

This prospective, randomized, controlled study aims to evaluate the impact of short-term intravenous iron dextran on postoperative recovery and the requirement for allogeneic red blood cells (RBC) transfusion in preoperative Iron-deficiency anemia (IDA) patients receiving orthopedic surgery, thus facilitating developing a simple and effective iron supplement approach for patients' recovery.

NCT ID: NCT03897673 Not yet recruiting - Anemia Clinical Trials

Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic Areas

OptiM
Start date: May 1, 2019
Phase: N/A
Study type: Interventional

Daily iron (ferrous sulfate, 2 mg/kg/day) or placebo syrup for first four months (112 days) of the 12-month (336-day) study. Children in the immediate iron group will receive iron syrup for the first three months (84 days) and placebo syrup for the fourth month. Children in the delayed iron group will receive placebo syrup for the first month (28 days) and iron syrup for the second, third, and fourth months.

NCT ID: NCT03893045 Not yet recruiting - Clinical trials for Iron Deficiency Anemia

A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects

Start date: May 2019
Phase: Phase 3
Study type: Interventional

This is a Phase 3, randomized, open-label, multicenter, study in male and female pediatric subjects (2 years to <18 years of age) with IDA, or felt by their clinician to be at risk of developing IDA. This study allows for enrollment of subjects with IDA regardless of etiology, except for CKD subjects (pediatric CKD subjects are being studied in a separate ferumoxytol protocol).

NCT ID: NCT03883841 Not yet recruiting - Clinical trials for Iron Deficiency Anemia

Fetal Vascular Hemodynamic Changes in Iron Deficiency Anemia

Start date: May 2019
Phase:
Study type: Observational

Iron deficiency anemia is a worldwide medical disorder. So far, it is the most common medical complication in pregnancy specially in developing countries. It is the cause of many adverse effects on mother and fetus and contributes significantly to high maternal mortality. Maternal iron deficiency anemia is frequently associated with premature delivery, low birth weight babies

NCT ID: NCT03873584 Not yet recruiting - Anemia Clinical Trials

Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy

IFAISTOS
Start date: June 1, 2019
Phase:
Study type: Observational

The treatment of anemia depends on its cause. Patients with underlying iron-deficient anemia should be treated or referred to a specialist (eg gynecologist, gastroenterologist) for treatment.deficiency anemia are global health problems and common medical conditions seen in everyday clinical practice. Iron is vital for biological functions, such as breathing, energy production, DNA synthesis, and cell proliferation. Iron deficiency refers to the reduction of iron stores and precedes the occurrence of iron deficiency anemia. Iron deficiency anemia is a more severe condition in which low levels of iron are associated with anemia and the presence of small cellular red blood cells.

NCT ID: NCT03873571 Not yet recruiting - Pregnancy Related Clinical Trials

Adherence of Iron Succinylate Therapy in Pregnancy

ARTEMIS
Start date: May 1, 2019
Phase:
Study type: Observational

According to the World Health Organization (WHO), anemia is the most common disease, affecting >1.5 billion people worldwide. Furthermore, iron deficiency anemia (IDA) accounts for 50% of cases of anemia. IDA is common during pregnancy and the postpartum period, and can lead to serious maternal and fetal complications. Measurement of serum ferritin has the highest sensitivity and specificity for diagnosis of IDA unless there is a concurrent inflammatory condition. The lower threshold value for hemoglobin (Hb) in pregnant women is <11 g/dL during the 1st and 3rd trimesters, and <10.5 g/dL during the 2nd trimester. In postpartum period a Hb concentration <10 g/dL indicates clinically significant anemia. Oral iron therapy is given as the first-line treatment for IDA.

NCT ID: NCT03840031 Not yet recruiting - Clinical trials for Iron Deficiency Anemia

Bio Fortified Iron OFSP Malawi

SASHA-II
Start date: February 11, 2019
Phase: N/A
Study type: Interventional

To combat Iron deficiency in Low and Middle-Income Countries, sustainable food-based solutions have to be implemented to serve populations, not only individuals. One solution is the introduction of iron biofortified staple crops on market level. Before market level introduction, we need to assess the iron bioavailability of the new biofortified breed. In our study this is the iron from a new bio fortified Orange Fleshed Sweet Potato breed. In this study we compare the fractional and total iron absorption of a normal Orange Flesh Sweet Potato variety and a high-iron bio fortified variety in Malawian women of reproductive age with marginal iron status.